Maternal serum CA 125 is of prognostic value in patients with uterine bleeding in the detection of small-for-gestational-age neonates

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 67, Issue 2, 1996, Pages 143-147

  Mazor, Moshe ^a   Bashiri, Asher ^a   Ghezzi, Fabio ^a   Maymon, Eli ^a   Kuperman, Oded ^a   Kopernik, Gideon ^a   Leiberman, Joseph R ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

CA 125; Preterm delivery; PROM; Small for gestational age; Uterine bleeding

Indexed keywords

CA 125 ANTIGEN;

ADULT; ARTICLE; DIAGNOSTIC VALUE; FEMALE; GESTATIONAL AGE; HUMAN; MAJOR CLINICAL STUDY; MATERNAL BLOOD; PREMATURE FETUS MEMBRANE RUPTURE; PREMATURE LABOR; PRIORITY JOURNAL; RISK ASSESSMENT; SMALL FOR DATE INFANT; UTERUS BLEEDING;

EID: 0030219749     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/0301-2115(96)02457-8     Document Type: Article

References (29)

1. [1] Bast RC Jr, Feeney M, Lazarus H, Nadler LM, Colvin RB, Knapp RC. Reactivity of a monoclonal antibody with human ovarian carcinoma. J Clin Invest 1981; 68: 1331-1337.
2. [2] Patsner B, Mann WJ, Cohen H, Loesch M. Predictive value of preoperative serum CA 125 levels in clinically localized and advanced endometrial carcinoma. Am J Obstet Gynecol 1988; 158: 399-402.
3. [3] Bast RC Jr, Klug TL, St John E, et al. A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer. New Engl J Med 1983; 309: 883-887.
4. [4] Lindgren J, Kuusela P, Hellstrom PE, Petterson T, Klockars M. The ovarian cancer associated antigen CA 125 in patients with pleural effusions. Eur J Cancer Clin Oncol 1988; 24: 737-739.
5. [5] Halila H, Stenman UH, Seppala M. Ovarian cancer CA 125 levels in pelvic inflammatory disease and pregnancy. Cancer 1986; 57: 1327-1329.
6. [6] Barbieri RL, Niloff JM, Bast RC Jr, Schaetzl E, Kisner RW, Knapp RC. Elevated serum concentration of CA 125 in patients with advanced endometriosis. Fertil Steril 1986;45: 630-634.
7. [7] Barbati A, Anceschi MM, Alberti P, Pomili G, Di Renzo GC, Cosmi EV. Ontogeny of CA 125 antigen in pregnancy: Immunoradiometric determination in amniotic fluid and immunohistochemical localization in fetal membranes. Am J Obstet Gynecol 1989; 160: 514-517.
8. [8] Bischof P. What do we know about the origin of CA125? Eur J Obstet Gynecol Reprod Biol 1993; 49: 93-98.
9. [9] Kabawat SE, Bast RC, Bhan AK, Welch WR, Knapp RC, Colvin RB. Tissue distribution of a coelomic-epithelium-related antigen recognized by the monoclonal antibody CA125. Int J Gynecol Pathol 1983b; 2: 275-285.
10. [10] Jacobs IJ, Fay TN, Stabile I, Bridges JE, Oram DH, Grudzinskas JG. The distribution of CA 125 in the reproductive tract of pregnant and non pregnant women. Br J Obstet Gynaecol 1988; 95: 1190-1194.
11. [11] Jacobs I, Bast RC, Jr. The CA 125 tumour-associated antigen: a review of the literature. Hum Reprod 1989; 4: 1-12.
12. [12] Quirk JG Jr, Brunson GL, Long CA, Bannon GA, Sanders M, O'Brien. CA 125 in tissues and amniotic fluid during pregnancy. Am J Obstet Gynecol 1988; 159: 644-649.
13. [13] O' Brien TJ, Hardin JW, Bannon GA, Norris JS, Quirk JG Jr. CA 125 antigen in human amniotic fluid and fetal membranes. Am J Obstet Gynecol 1986; 155: 50-55.
14. [14] Lelle RJ, Henkel E, Leinemann D, Goeschen K. Measurement of CEA, TPA, Neopterin, CA125, CA153 and CA199 in sera of pregnant women, umbilical cord blood and amniotic fluid. Gynecol Obstet Invest 1989; 27: 137-142.
15. [15] Niloff JM, Knapp RC, Schaetzl E, Reynolds C, Bast RC. CA125 antigen levels in Obstetric and Gynecologic patients. Obstet Gynecol 1984; 64: 703-707.
16. [16] Seki K, Kikuchi T, Kato. Increased serum CA-125 levels during the first trimester of pregnancy. Acta Obstet Gynecol Scand 1986; 65: 583-585.
17. [17] Quirk JG, Brunson GL, Long CA, Bannon GA, Sanders MM, O'Brien TJ. CA-125 in tissues and amniotic fluid during pregnancy. Am J Obstet Gynecol 1988; 159: 644-649.
18. [18] Witt BR, Miles R, Wolf GC, Koulianos GT, Thorneycroft IH. CA125 levels in abruptio placentae. Am J Obstet Gynecol 1991; 164: 1225-1258.
19. [19] Williams MA, Hickok DE, Zingheim RW, Zebelman AM. Maternal serum CA125 levels in the diagnosis of abruptio placentae. Obstet Gynecol 1993; 82: 808-812.
20. [20] Check JH, Nowroozi K, Winkel CA, Johnson T, Seefried L. Serum CA 125 levels in early pregnancy and subsequent spontaneous abortion. Obstet Gynecol 1990; 75: 742-744.
21. [21] Takahashi K, Yamane Y, Yoshino K, Shibukawa T, Matsunaga I, Kitao M. Studies on serum CA 125 levels in pregnant women. Acta Obstet Gynecol Jpn 1985; 37: 1931-1934.
22. [22] Leiberman JR, Fraser D, Weitzman S, Glezerman M. Birth-weight curves in southern Israel population. Isr J Med Sci 1993; 29: 198-203.
23. [23] Haga Y, Sakamoto K, Egami H, Yoshimura R, Akagi M. Evaluation of serum CA 125 values in healthy individuals and pregnant women. Am J Med Sci 1986; 292: 25-29.
24. [24] Seki K, Kikuchi Y, Uesato T, Kato K. Increased serum CA 125 levels during the first trimester of pregnancy. Acta Obstet Gynecol Scand 1986; 65: 583-585.
25. [25] De Wolf F, Brosens I, Renaer M. Fetal growth retardation and the maternal arterial supply of the human placenta in the absence of sustained hypertension. Br J Obstet Gynaecol 1980; 87: 678-685.
26. [26] Sheppard BL, Bonnar J. The ultrastructure of the arterial supply of the human placenta in pregnancy complicated by fetal growth retardation. Br J Obstet Gynaecol 1976; 83:948-959.
27. [27] Labarrere C, Mullen E. Fibrinoid and trophoblastic necrosis with massive chronic intervillositis: an extreme variant of villitis of unknown etiology. Am J Reprod Immunol Microbiol 1987; 15(3): 85-91.
28. [28] Teasdale F. Idiopathic intrauterine growth retardation:histomorphometry of the human placenta. Placenta 1984; 5: 83-92.
29. [29] Danielian PJ. CA 125 and preterm prelabour rupture of the membranes. Br J Obstet Gynaecol 1991; 98: 835-836.